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Abstract
p120 loss destabilizes E-cadherin and could therefore result in tumor and/or metastasis-promoting activities similar to those
caused by E-cadherin downregulation. Previously, we reported that p120 is essential in the intestine for barrier function,
epithelial homeostasis and survival. Conditional p120 ablation in the mouse intestine induced severe inflammatory bowel
disease, but long-term cancer-related studies were impossible because none of the animals survived longer than 21 days.
Here, we used a tamoxifen-inducible mouse model (Vil-Cre-ER
T2;p120
fl/fl) to limit the extent of p120 ablation and thereby
enable long-term studies. Reducing p120 KO to ,10% of the intestinal epithelium produced long-lived animals outwardly
indistinguishable from controls. Effects of prolonged p120 absence were then evaluated at intervals spanning 2 to 18
months. At all time points, immunostaining revealed microdomains of p120-null epithelium interspersed with normal
epithelium. Thus, stochastic p120 ablation is compatible with crypt progenitor cell function and permitted lifelong renewal
of the p120-null cells. Consistent with previous observations, a barrier defect and frequent infiltration of neutrophils was
observed, suggesting that focal p120 loss generates a microenvironment disposed to chronic inflammation. We report that
45% of these animals developed tumors within 18 months of tamoxifen induction. Interestingly, b-catenin was upregulated
in the majority, but none of the tumors were p120 null. Although further work is required to directly establish mechanism,
we conclude that limited p120 ablation can promote tumorigenesis by an indirect non-cell autonomous mechanism. Given
that byproducts of inflammation are known to be highly mutagenic, we suggest that tumorigenesis in this model is
ultimately driven by the lifelong inability to heal chronic wounds and the substantially increased rates of stochastic gene
mutation in tissue microenvironments subjected to chronic inflammation. Indeed, although technical issues precluded
direct identification of mutations, b-catenin upregulation in human colon cancer almost invariably reflects mutations in APC
and/or b-catenin.
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Introduction
The inability to generate and maintain epithelial integrity is a
major causative factor in inflammatory disease and cancer [1,2].
In a number of inflammatory diseases, the initiating event is
difficult to pinpoint because epithelial damage can induce
inflammation and inflammation can induce epithelial damage.
We showed previously that p120-catenin (hereafter p120)
knockout in the epithelium of the mouse small and large intestines
resulted in mucosal damage and inflammation leading to bleeding
and death within the first three weeks of life [3]. The animals were
born with a barrier defect suggesting that the inevitable
inflammatory response was triggered by weak cell-cell adhesion
and mucosal exposure to intestinal flora. Other mechanisms may
contribute, however, as p120 knockdown in a polarizing colon
cancer cell line (HCA-7) induces strong neutrophil attachment [3],
and p120 ablation in the epidermis activates an NFkB-dependent
inflammatory response but no barrier defect [4]. Mechanism
aside, our previous mouse model precluded study of the possible
tumorigenic effects of p120 loss due to the lethal consequences of
knocking out p120 in a high proportion of the intestinal
epithelium.
To date, much of the evidence linking p120 to human cancer is
based on its physical and functional relationships with classical
cadherins, E-cadherin in particular. Classical cadherins comprise a
family of transmembrane cell-cell adhesion receptors important in
development, morphogenesis, and cancer (reviewed in [5,6]). They
are regulated, in part, by p120-catenin and b-catenin, cytoplasmic
armadillo repeat proteins that interact directly with distinct sites on
the cadherin tail. b-catenin recruits a-catenin to the complex, and
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interactions with the actin cytoskeleton [11,12,13]. In contrast,
p120 binding controls cadherin stability and retention at the cell
surface [14,15]. If p120 is removed (e.g., by knockout or
knockdown), classical cadherins, along with associated a- and b-
catenins, are internalized and degraded. p120 also modulates the
activities of several RhoGTPases [16], suggesting that the catenins
in general coordinate a functional interface between cadherins and
various other factors that interact with the actin cytoskeleton.
Epithelial (E)-cadherin is the most prominent cell-cell adhesion
receptor in epithelial cells and is widely regarded as a master
organizer of the epithelial phenotype [5]. It functions as a classic
tumor suppressor in gastric cancer [17] and lobular carcinoma of
the breast [18], where germline mutations in the E-cadherin gene
are responsible for familial inheritance. In most other cancers, E-
cadherin is considered a metastasis suppressor because it is
downregulated in advanced tumors and plays a causal role in the
transition to metastasis [19,20,21,22,23]. Because p120 regulates
E-cadherin function and stability, it is widely suspected that p120
itself is a tumor and/or metastasis suppressor.
Over 85% of human colorectal cancer (CRC) begins with
mutation of the Adenomatous Polyposis Coli gene (APC) [24]. APC
loss-of-function stabilizes a pool of b-catenin, which then associates
with the transcription factor TCF4 to drive transcription of the c-
Myc oncogene and other cancer-relevant genes. Direct activation
of b-catenin by mutation at regulatory serine/threonine phos-
phorylation sites has a similar effect, and, indeed, approximately
5% of human CRCs are thought to be initiated in this way [24].
Thus, mutations in APC and b-catenin are believed to account for
the initiation of more than 90% of human CRC.
Notably, previous work suggests a cell-autonomous role for
p120 in suppression of inflammation [4]. In contrast to the
intestine, p120 ablation in the epidermis has no discernable effect
on either cell-cell adhesion or barrier function despite reduced
levels of both E- and P-cadherins. Instead, these mice develop
severe epidermal inflammation due to cell-autonomous activation
of NFkB [4]. Thus, in addition to its well-established role in cell-
cell adhesion, p120 appears to play an important role in
suppressing inflammation in keratinocytes, and probably other
cell types.
Previously, we reported that p120 is essential in the intestine for
epithelial homeostasis and life [3]. Using a Villin-Cre driver and
our p120 conditional knockout mouse, we evaluated the effects of
targeted p120 ablation in the small intestine and colon. Although
superficially normal at birth, KO animals declined rapidly and
died within 21 days. Cell-cell adhesion defects and inflammation
led to progressive mucosal erosion and terminal bleeding.
Interestingly, the mice were born with a chronic barrier defect,
a condition almost always associated with inflammation. On the
other hand, there was also evidence for other cell-autonomous
effects of p120 downregulation. Specifically, neutrophil attach-
ment in vitro to p120-deficient epithelial monolayers was
dramatically increased and resulted in selective upregulation of
COX-2 in the neutrophils. Thus, several different events
associated with p120-deficiency appear to significantly promote
inflammation.
Here, we report that p120 KO by itself, in just a small fraction
of the intestinal epithelium (,5–15%), results in a tumor incidence
of 45% by 18 months post tamoxifen. Surprisingly, however,
outright p120 loss was not observed in the tumor itself. Instead,
p120 expression was retained in each of the 16 adenomas
analyzed, albeit at apparently lower levels, indicating that p120
loss is not directly causative. The majority of adenomas, however,
showed increased levels of cytoplasmic/nuclear b-catenin, sug-
gesting driver mutations in APC, b-catenin, or other members of
the canonical Wnt pathway. To approach mechanism, we
examined in vitro effects of p120 KD in a colon cancer cell line
(HCA-7) by gene expression and cytokine-array profiling,
immunofluorescent staining and Real Time rtPCR. The striking
upregulation of NFkB observed in p120 knockout epidermis was
not evident [4], but cytokines associated with neutrophil
infiltration (i.e., CXCL1, IL-8 and PDGF) were modestly elevated
[25,26,27]. The latter is consistent with our observation of obvious
neutrophil recruitment to p120 null areas. Collectively, these data
raise the possiblility that the tumors result from an increased rate
of gene mutation, a well-established consequence of long-term
unresolved inflammation [28]. Over the lifetime of the animals,
the cumulative effects of p120-associated inflammation are likely
to be significant, and not unlike the tumorigenic effects of
ulcerative colitis, where the risk of cancer is increased by ,18%
over 30 years [29].
Results
Regulated p120 KO in the small and large intestine
Previously, we reported that conditional p120 knockout in the
small intestine and colon (using a constitutively expressed Villin-
Cre mouse driver) causes a striking IBD-like condition and death
within the first few weeks of life [3]. Here, we crossed the same
conditional p120 KO mouse to a tamoxifen-inducible Villin-Cre
transgenic mouse driver (Vil-Cre-ER
T2) with the goal of limiting
p120 KO to levels compatible with long-term survival. As with the
previous model, the Vil-Cre-ER
T2 mouse permits selective
targeting of Cre-ER
T2 expression to the epithelial compartment
of the small and large intestines, but in addition provides the
opportunity to precisely control the timing and amount of Cre
activity through administration of tamoxifen [30].
To identify an appropriate regimen of tamoxifen administra-
tion, the timing and dose of tamoxifen given was varied in a series
of pilot experiments (not shown). The amount of p120 KO in the
small and large intestines was visualized 2 months later by
immunofluorescence staining of tissue sections (Figures 1A and 1B)
and quantified (data not shown). Age-matched Vil-Cre-ER
T2;
p120
F/F treated with oil were used as controls for tamoxifen-
treated animals to rule out the possibility of recombination in the
absence of tamoxifen. The tamoxifen regimen selected (IP
injection of 1 mg/20 g/day for 3 days) reproducibly induced
,5% p120 knockout (1 out of every 20 crypts) in the small
intestine (Figure 1A) and ,15% knockout (3 out of every 20
crypts) in the colon (Figure 1B) with little, if any, overt effects on
the health of the animals. p120 null crypts were usually distributed
randomly throughout the small intestine and colon. The images in
Figure 1 illustrate a cluster of p120-null crypts in order to show
multiple examples of p120-negativity in a single figure. Interest-
ingly, the levels of p120 ablation observed at two months persisted
with little change over the lifetime of the animals (referred to
hereafter as ‘‘limited’’ p120 KO). We were surprised to find that
p120 ablation did not appreciably compromise progenitor cell
function, and despite the effects of p120-loss on cell-cell adhesion,
p120-null progenitor cells were properly retained within the stem
cell niche. These experiments define an effective protocol for
generating a consistent level of ‘‘limited’’ p120 KO for long term
evaluation of the effects of p120 ablation in the intestine.
At two months post tamoxifen, p120 knockout in both the small
and large intestines manifested as columns of p120-negative cells
derived from the clonal progeny of p120-ablated stem cells.
However, in the small intestine, p120 null villi were invariably
broken off (arrows, Figure 1A, iv), apparently weakened by p120
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cadherin. This condition was chronic, apparently persisting for the
lifetime of the animal. p120-null crypts remained in the small
intestine, but p120-negative villi were rarely seen. In contrast, the
p120 null columns in the colon were largely intact (Figure 1B,
arrows), except for minor structural weakness and occasional signs
of erosion at the top of the crypt (Figure 1B, arrows). The colon
lacks the free-standing villi found in the small intestine, and instead
is composed of deep crypts containing columns of epithelial cells
that physically support one another. Because of this arrangement,
Figure 1. Limited ablation of p120 in the small and large Intestine. At the two-month time point sections of the small (A) and large (B)
intestine were co-stained with p120 (i and iv) and E-cadherin (ii and v). Arrows indicate regions of p120 KO.
doi:10.1371/journal.pone.0019880.g001
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tissue that appear to protect the p120-null columns and thereby
mask the effects of structural weakness.
Limited p120 KO induces formation of cystic crypts
To further examine the effects of limited p120 ablation over time,
tamoxifen-treated animals wereagedand thensacrificedat 2, 4, 6,8,
12, and 18 months post tamoxifen. Paraffin-embedded sections were
initially examined by hematoxylin and eosin (H&E) staining and by
double immunofluorescent staining with antibodies to p120 and E-
cadherin (Figure 2A) to evaluate the effects of p120 ablation at the
tissue level. Interestingly, a small number of cystic crypts were
observed in p120 KO, but not control animals. Quantification
revealed an average of ,5 cystic crypts per p120 KO animal, all of
which were derived from p120 null crypts. The size of the cysts in
any given animal varied widely (e.g., Figure 2A, compare top and
bottom panels) and this was true at every time point from 2 to 18
months. The average number of cysts per animal was relatively
constant over this period, suggesting a steady state condition
whereby new cysts emerge on a regular basis and large cysts are
lost and/or removed. Notably, the height of the epithelial lining of
the smaller cysts (Figure2A,arrows)isrelatively normal but becomes
progressively thinner as the cysts enlarge. For example, the lower
panels (Figure 2A) show an enlarged cyst encased by an epithelial
lining that has become so thin as to be almost unrecognizable
(arrowheads). Overall, these data suggest that p120-null crypts
transform at a low but steady rate into cysts, which expand in a
predictable fashion until they are eventually reabsorbed or ruptured.
The cysts arise initially from p120 null crypts that are
indistinguishable from others until they begin to increase in size.
Presumably, the stem cells that normally reside in the crypts are
viable and continue to generate new cells that are shed into the
lumen and die. To evaluate thefate ofthese cells,a panelof 12 small
to moderately sized cysts was analyzed by staining for cleaved
caspase-3,a markerofapoptosis(Figure 2B).Ofthese,oneappeared
to lack apoptotic cells (panel ii) whereas the other 11 ranged from a
few (panel iii) to many (panel iv) apoptotic cells, suggesting that the
most prominent contents of late-stage cysts are remnants of
apoptotic epithelial cells. In general, neutrophils were also observed
in and around p120-negative cysts and cyst contents appeared to
evolvealongwithincreasingsizeintoamore complicatedmixtureof
apoptotic, necrotic, and inflammatory cells.
Figure 2C illustrates a rare example in the small intestine where
adjacent columns of p120-null cells appeared to protect an entire
villus wall, permitting its extension to the surface of the lumen
(panel i). Panel ii illustrates adhesive failure of unprotected p120-
null cells relative to surrounding p120 intact counterparts.
p120 ablation in the intestine does not by itself increase
cell proliferation
Previously, we observed that there was a uniform 3-fold increase
in intestinal epithelial proliferation in the constitutive p120 KO
mouse [3], but it was not possible to distinguish between cell-
autonomous effects versus a spectrum of significant indirect effects
associated with tissue damage and widespread inflammation.
Therefore, we revisited the issue here using the Vil-Cre-ER
T2/
p120 KO mice where cell-autonomous effects of p120 ablation
were largely confined to small pockets of p120 ablation (e.g.,
Figure 3, arrows). Under these conditions, BrdU pulse-chase
experiments conducted 2 months post tamoxifen show clearly that
p120 ablation by itself has very little effect on proliferation
(Figure 3). p120-null crypts were identified by immunofluores-
cence and selectively analyzed for BrdU-positive cells (Figure 3A,
arrows). The number of BrdU-positive nuclei/ crypt was
compared to that of control animals lacking p120 knockout. No
significant difference in proliferation was observed (p=1) as both
showed an average of 4.25 BrdU-positive nuclei/ crypt (Figure 3B).
Neutrophil infiltration and barrier dysfunction are directly
associated with p120 ablation
We observed previously in our constitutive p120 KO mouse that
epithelial proliferation was uniformly increased due to a widespread
inflammatory field effect [3]. However, in vitro experiments with HCA-
7 KD cells revealed a striking cell-autonomous increase in neutrophil
attachment to p120-deficient monolayers. Here, although the effects
of p120 ablation on cell proliferation (relative to the previous model)
were reversed by limiting the extent of p120 KO, selective recruitment
of neutrophils to p120-null fields was retained (Figure 4A). Recruit-
ment wasmore pronounced in the colon, but was also observed clearly
in the small intestine, as quantified in Figure 4B. Neutrophil numbers
in the p120 KO colon were 3.9-fold higher than in control colons
(p=.0092). The average number of neutrophils in the p120 KO small
intestine was 4.7-fold higher than in control small intestine tissue, but
the result narrowly missed statistical significance (p=.06). These
observations suggest that p120 ablation affects the immediate
microenvironment in ways that participate in both the homing and
attachment of neutrophils to pockets of p120 null epithelium.
In addition, in vivo permeability assays revealed a clear barrier
defect (Figure 4C), even though the p120 KO component of the
overall gut lining was on average less than 10% of the total
epithelium. p120 KO and control animals were gavaged with
FITC-dextran and assayed 4 h later for leakage of FITC-dextran
into the bloodstream. Relative to control mice, serum levels of
FITC-dextran were 3.3-fold higher in Vil-Cre-ER
T2/p120 KO
mice (p=.03), indicating that even limited p120-ablation (5–15%)
leads to readily detectable defects in epithelial permeability.
Limited p120 ablation indirectly induces tumorigenesis
Although several lines of evidence have suggested a tumor
suppressor role for p120, we did not expect that p120 ablation in
the absence of other genetic defects would be tumorigenic.
Surprisingly, intestinal tumors were detected in about half of the
mice at the 12-month time point and then again at 18 months.
Table 1 combines the tumor data from both time points and
breaks it down according to tumor type, location, number, and
expression patterns of b-catenin. Overall, 45% (14/31) of the Vil-
Cre-ER
T2/p120 KO mice examined at 12 or 18 months
developed tumors while none were detected in age matched
control (n=29) animals. The tumors occurred in the small
intestine or the cecum and were classified as one of four types by
expert pathologist, Dr. M.K. Washington: small adenoma
(Figure 5A), adenoma (Figure 5B), adenocarcinoma (Figure 5C),
and mucinous adenocarcinoma (Figure 5D). The adenocarcinoma
and mucinous adenocarcinomas were locally invasive, but invasion
into the vasculature was not observed. Liver tissue was collected
from mice at both 12- and 18-month time points, but metastases
were not visible grossly or with H&E staining.
Given the relatively high tumor incidence, we then examined
p120 levels by immunofluorescent staining expecting to find that
most, if not all tumors would be p120 null. Instead, none of the 16
tumors lacked p120, although in most cases p120 staining
appeared to be selectively reduced. On extremely rare occasions,
a few p120-negative crypts were found alongside adenomatous
tissue (e.g., Figure 5A, arrowheads), but we were not able to find
any examples of p120 loss that were obviously adenomatous.
Thus, the mechanism of tumorigenesis is mostly likely indirect.
Nonetheless, p120 levels were consistently reduced in both small
and midsized adenomas (e.g., Figures 5A, i; 5B, i). The top panels
p120 KO and Tumorigenesis in the Mouse Intestine
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antibodies to p120 and b-catenin, respectively. Interestingly, in the
small adenomas, b-catenin staining was unremarkable and
essentially identical to that of p120 in both location and intensity.
In striking contrast, the large adenomas were defined by marked
upregulation and mislocalization of b-catenin (Figure 5B, ii),
whereas p120 levels remained decreased (Figure 5B, i), as also
observed in the small adenomas (Figure 5A, i).
Figure 2. Cystic crypts develop in the absence of p120. At the two-month time point small intestine sections were (A) co-stained with p120
and E-cadherin or hematoxylin and eosin. Arrows and arrowheads indicate the p120-negative epithelium lining the cyst walls. 206magnification. (B)
and (C) WT and p120 KO small intestine tissue was co-stained for p120 and cleaved caspase-3, a marker for apoptosis. Eleven of the twelve cysts
stained contained apoptotic cells (arrows). 206magnification. (C) Arrowheads point to poorly adhesive, rounded cells which often result from p120
loss. 636magnification.
doi:10.1371/journal.pone.0019880.g002
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adenocarcinomas (Figure 5A, ix–x), which are thought to arise
through loss of TGFb signaling [31,32]. Similar tumors have been
observed in Smad3 mutant mice [32,33]. The presence of tumors
arising through different (i.e., Wnt- and TGFb-associated)
pathways is consistent with a primary mechanism associated with
increased overall rates of gene mutation.
p120 loss induces expression of neutrophil
chemoattractants
Studies of p120 knockout in the skin suggest that p120 ablation
can induce inflammation by cell-autonomous mechanism(s)
independent of barrier status [4]. Whether a similar barrier-
independent mechanism exists in the intestine is unknown. To
examine effects of p120 knockdown in an environment where the
Figure 3. Proliferation is normal in the limited p120 ablation intestine. At the two-month time point, mice were injected with BrdU and
sacrificed 2 hours later to measure proliferation. (A) Colon sections were co-stained for p120 and BrdU. Arrows indicate regions of p120 KO. (B) BrdU-
positive nuclei were quantified in control and p120 KO tissue. No significant difference in proliferation was observed (p=1) as both control and
knockout tissues had an average of 4.25 BrdU-positive nuclei/ crypt.
doi:10.1371/journal.pone.0019880.g003
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microarray experiments in the p120 KD HCA-7 cell system
described previously [3]. First, to examine the level of p120 KD,
Western blots were performed (Figure 6A). Subsequent prelimi-
nary microarray experiments indicated that several key mediators
of neutrophil recruitment were modestly upregulated in the
absence of p120 (e.g., IL-8, CXCl1, PDGF-BB), providing a
partial explanation for the recruitment of neutrophils [25,26,27].
CXCL1 and IL-8 were further validated by Real Time
rtPCR(Figure 6B). For CXCL1 (GRO), IL-8 and PDGF-BB,
secreted protein levels were quantified directly by cytokine array
using media supernatants (Figure 6C). Collectively, the data is
consistent with the notion that p120-deficiency upregulates genes
involved in neutrophil attraction [25,26,27], as well as the
proinflammatory cytokines IL-13 and SCF (Figure 6C). The
former is consistent with selective homing of neutrophils to pockets
of p120-null epithelium, while the latter supports prior findings in
skin suggesting that p120 suppresses inflammation.
Discussion
We showed previously that constitutive p120 KO in the mouse
intestine induces severe and ultimately lethal inflammatory bowel
disease [3]. However, we were unable to evaluate effects of p120
ablation on tumorigenesis because the animals died by 21 days of
age. Here, we have used an inducible system to limit the extent of
p120 knockout to levels that do not cause IBD or other overt
abnormalities. We report that under these conditions, almost half
of the animals develop adenomas with a latency of 12–18 months.
Taken together, the results are highly reminiscent of the DN-
cadherin mouse model of inflammatory bowel disease, in which
mice develop a Crohn’s-like phenotype by three months of age
and adenomas by six [34]. We (and others) have shown previously
that DN-cadherin expression causes internalization and degrada-
tion of endogenous cadherins by sequestering p120 [3,14,15,35].
Thus, p120-ablation and forced expression of DN-cadherin
appear to be mechanistically equivalent and have the same
spectrum of short and long-term consequences in the intestine.
These observations suggest a physiologically relevant context for
interpretation of DN-cadherin phenotypes. Specifically, DN-
cadherin phenotypes in mice most likely predict consequences of
p120 downregulation, a phenomenon frequently observed in
human epithelial cancers [36].
Unexpectedly, although microdomains of p120 KO were
ubiquitously present throughout the intestinal epithelium, they
were virtually absent in adenomas arising from these animals. It is
increasingly evident, however, from our unpublished work in
various APC mutant mouse models that outright p120 ablation (as
opposed to reduced p120 levels) may be incompatible with cell
viability in APC-mutant adenomas (data not shown). Together,
these observations indicate that the tumorigenic mechanism
associated with limited p120 ablation is not cell autonomous, but
instead derives from secondary effects of p120 loss that influence
cell-transformation in nearby p120 positive cells. The simplest
explanation is that foci of p120-null tissue comprise chronically
inflamed microenvironments that persist throughout the intestine
for the lifetime of the animal. Chronic inflammation is a well-
established driver of tumorigenesis [37] associated with toxic
byproducts (e.g., reactive oxygen species [28,38]) and high DNA
mutation rates [37,39]. Although technical and tissue limitations
precluded efforts to identify specific gene mutations, b-catenin
upregulation was used as a surrogate marker to show clear
canonical Wnt pathway activation in 10 of 16 tumors analyzed
(e.g., Figure 5B). Collectively, these findings are consistent with a
tumorigenic mechanism involving chronic inflammation and gene
mutations in APC, b-catenin or other members of the canonical
Wnt pathway [40,41,42].
Notably, ulcerative colitis (UC) patients have an estimated 18%
risk of developing CRC within 30 years of disease onset, and
approximately 15% of patients with inflammatory bowel disease
die of CRC [29]. Several relevant mouse models have been
developed to study colitis-associated cancer (CAC). For example,
IL-10 knockout mice exhibit a generalized enterocolitis and, in
fact, 60% develop colorectal adenocarcinomas by 6 months of age
[43]. Furthermore, in the dextran sulfate sodium (DSS) model of
chronic colitis, 50% of mice develop tumors within 2 weeks
following the last of nine DSS cycles [44], an incidence almost
identical to that of our model. DSS alone is not an efficient model
for studying CAC, so the more commonly utilized model employs
a single dose of azoxymethane to initiate tumorigenesis followed
by 3 cycles of DSS [45]. Tumors are observed throughout the
colon with the highest concentration occurring in the left colon
where the inflammation is most severe [45]. Although an
exogenous mutagen was not used in our model, the overall
process is probably similar in that both are likely to be driven by
inflammation and ultimately mutation of known colon cancer
genes (e.g., members of Wnt and/or TGFb pathways).
Since the tumors in our model retained low levels of p120
expression, we explored the possibility that p120 is a haploinsuffi-
cient tumor suppressor. Tamoxifen-treated Vil-Cre-ER
T2;p120
F/+
mice were aged for 15 months (data not shown). No difference
between heterozygous and wildtype mice was observed suggesting
that haplosinsufficiency is not responsible for tumorigenesis in Vil-
Cre-ER
T2/ p120 KO mice.
A central goal of this study was to reduce the extent of p120
knockout in theintestinal epithelium to levels that permitted long-
term analyses. Indeed, with knockout levels of ,10%, the animals
lived to old age and were outwardly identical to control littermates.
The widespread inflammatory field effect observed in the previous
model (following constitutive p120 KO) resolved completely, as did
elevated rates of apparent compensatory cell proliferation. In
contrast, the barrier defect did not resolve, confirming that reduced
barrier function is indeed a cell-autonomous effect of p120-loss.
Another direct consequence of p120 ablation was observed
primarily in the small intestine, where p120-negative villi were
invariably damaged or broken off altogether (Figure 1A), apparently
reflecting persistent irreparable wounds (e.g., Figure 2C). In the
colon, p120-negative crypts remained largely intact because the
colonic architecture physically protected them (Figure 1B). The
relatively selective effect of p120 ablation on the small intestine
architecture could account, in part, for the higher tumor incidence
in the small verses large intestine. For example, in humans with
colitis-associated cancer, neoplastic regions are generally located
adjacent to regenerative mucosa [45] which may undergo similar
cycles of chronic wounding and repair. Lastly, the consistent
Figure 4. Neutrophils infiltrate p120 null regions of the small intestine and colon. (A) p120 KO small intestine and colon sections were co-
stained for p120 and neutrophils. Arrows and arrowheads indicate regions of p120 ablation. (B) Neutrophils were quantified in oil and tamoxifen-
induced small intestine (p=.06) and colon (p=.0092) samples. (C) At the two-month time point, mice were gavaged with FITC-dextran, and serum
levels of FITC-dextran were measured to test for an intestinal permeability defect. FITC-dextran levels were significantly higher (3.3-fold) in p120 KO
mice (p=.03).
doi:10.1371/journal.pone.0019880.g004
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p120 knockout, but the cause(s) and/or consequence(s) of cystic
crypt formation are unknown. They clearly were not direct tumor
precursors because none of the tumors from these mice were p120
null, but the cysts were often associated with neutrophilic infiltrates
and inflammation. Though not necessarily related, cysts are
frequently observed in human CRC and in adenomas in most
mouse models of colon cancer [43,46,47].
Although obvious neutrophil homing to p120 negative foci
was observed, we were largely unsuccessful in attempts to
definitively link p120 ablation to particular cell autonomous
mechanisms of neutrophil recruitment. Neutrophils have
positive roles in tissue repair [48], but also generate reactive
oxygen and nitrogen species [28,38], which can lead to DNA
damage and tumorigenesis [37,39]. Micro- and cytokine-array
experiments did turn up modestly elevated mRNA and protein
expression levels of neutrophil-attracting chemokines, CXCL1
and IL-8, and other potentially relevant factors (Figure 6),
following in vitro knockdown of p120 in HCA7 cells. However,
the effects overall were moderate and appeared insignificant
relative to the extraordinary upregulation of cytokines associ-
ated with p120 ablation in skin.
Overall, the data reveal that stochastic p120 knockout in the
mouse intestine can lead to adenoma formation, consistent with
the possibility of a tumor suppressor function. Although these
experiments were, in fact, designedt oe v a l u a t et h i sp o s s i b i l i t y ,
our original working hypothesis was based conceptually on well-
established effects of E-cadherin downregulation in cancer (i.e.,
increased cell motility, epithelial-mesenchymal transition,
invasiveness and/or reduced contact inhibition of cell growth).
Clearly, these would be cell autonomous effects of p120 loss and
are therefore inconsistent with the fact that none of the tumors
from these animals were p120 null. Instead, our results suggest a
more complicated scenario that may in part reflect a key
difference between tumor initiation and subsequent events
relevant to tumor progression. Tumorigenesis in these animals
is most likely a secondary effect of lifelong chronic inflamma-
tion, excessive DNA damage, and ultimately, direct mutation of
genes already known to promote intestinal cancer. Whether
p120 downregulation does in fact constitute a causal factor in
human IBD and/or intestinal cancer remains unclear. Howev-
er, the frequent occurrence of p120 downregulation in most
epithelial cancers, including CRC [49,50,51], is extensively
documented (reviewed in [36]), and important roles for p120




All experiments involving animals were approved by the
Vanderbilt University Institutional Animal Care and Use
Committee for protocol numbers M/05/116 and M/07/061.
Mice
Mice were maintained under a strict 12-hour light/dark cycle
and with free access to chow and water. Mice containing the
floxed p120 allele (F) were generated as described previously by
our lab [52]. p120
F/F mice (fully backcrossed onto a C57Bl/6
background) were crossed with Vil-Cre-ER
T2 mice [30] to target
inducible p120 ablation to the small intestine and colon. Six-week-
old Vil-Cre-ER
T2; p120
F/F were intraperitoneally injected with
1 mg/20 g/day of tamoxifen for 3 days. Age-matched Vil-Cre-
ER
T2; p120
F/F treated with oil were used as controls for
tamoxifen-treated animals.
Immunohistochemistry
Swiss-rolled intestinal tissue was fixed in formalin overnight at
4uC and then embedded in paraffin. Paraffin-embedded sections
(5 mm) were prepared for H&E staining and immunohistochem-
istry (IHC). Sodium citrate antigen retrieval was used for all
antibodies except for anti-BrdU. For fluorescent IHC, samples
were incubated with primary and secondary antibodies overnight
at 4uC and for 2 hr at room temperature, respectively.
The following primary antibodies were utilized: rabbit anti-
p120 (F1aSH); pp120 (#610133) and anti-E-cadherin (#610181)
from BD Transduction Laboratories; anti-b-catenin (#C2206
Sigma); anti-BrdU (Accurate Chemical & Scientific Corp.
#OBT0030); rat-anti-mouse neutrophils (#MCA771GA Serotec);
and anti-cleaved caspase-3 (Cell Signaling). Secondary antibodies,
conjugated to either the 488 Alexa-fluor or the 594 Alexa-fluor,
were obtained from Molecular Probes.
Proliferation
To determine proliferation rates, mice were injected intraper-
itoneally with BrdU 2 h before sacrificing. BrdU-positive nuclei
were counted in p120-null crypts and compared to the number in
oil-treated control mice.
In vivo permeability assay
Intestinal paracellular permeability was determined by mea-
suring the appearance of a marker, FITC-dextran (4.4 kDa
Table 1. Tumor types and histological patterns.
Tumor type Age Location # of Tumors b-catenin
Small Adenoma 12 months Small Intestine 3 Junctional
Small Adenoma 12 months Small Intestine 1 Cytoplasmic/nuclear
Small Adenoma 18 months Cecum 1 Junctional/cytoplasmic
Adenoma 12 months Small intestine 3 Cytoplasmic/nuclear
Adenoma 18 months Small Intestine 4 Cytoplasmic/nuclear
Adenocarcinoma 18 months Jejunum 1 Cytoplasmic/nuclear
Mucinous Adenocarcinoma 18 months Ileum 1 Junctional
Mucinous Adenocarcinoma 12 months Cecum 2 Junctional
Total number of tumors 16 10/16
doi:10.1371/journal.pone.0019880.t001
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KO mice were fasted for 12 hours. Then, 22 ml/kg body weight
of PBS (pH 7.4) containing 22 mg/ml FITC-dextran were
administered by gavage. Four hours later a blood sample
(150 ml) was obtained and centrifuged to separate plasma. Plasma
(50 ml) was mixed with an equal volume of PBS (pH 7.4). The
concentration of fluorescein was determined using a fluorimeter
with an excitation wavelength at 485 nm and an emission
Figure 5. p120 is decreased, not gone, in tumors from p120 KO mice. p120 KO tumors of different stages were co-stained with p120 and b-
catenin or H&E. (A) Small adenoma. Arrowheads indicate p120-null crypts. (B) Adenoma (C) Adenocarcinoma. Arrowheads point to invasive
adenocarcinoma. (D) Mucinous adenocarcinoma. All of the tumors examined exhibited reduced but not complete loss of p120.
doi:10.1371/journal.pone.0019880.g005
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PLoS ONE | www.plosone.org 10 May 2011 | Volume 6 | Issue 5 | e19880Figure 6. Cytokines are upregulated in p120 KD HCA-7 cells. (A) Western blot for p120. Control HCA-7 cells are in lane 1 and p120 KD cells are
in lane 2. Tubulin is shown as a loading control (B) Real time rtPCR for IL-8 and CXCL1. IL-8 and CXCL1 levels were significantly higher (p=.013 and
p=.015 respectively) in p120KD HCA-7 cells than WT HCA-7 cells. (C) Cytokine array on proteins secreted into cell media. GRO (p=.06), IL-8
(p=.0036), IL-13 (p=.012), SCF (p=.012) and PDGF (p=.039) were increased, and Eotaxin-2 (p=.03) was decreased in p120KD HCA-7 cells.
Data=mean 6 standard deviation.
doi:10.1371/journal.pone.0019880.g006
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marker as standard.
Cell lines, reagents, constructs
Cell culture conditions for HCA-7 cells have been described
previously in detail [3]. Lentiviral vectors containing a GFP
cassette and expressing either shRNA directed against human
p120 or an empty control vector were constructed in pLentiLox
(pLL) 5.0 vectors [54]. Production of pLL virus for shRNA
expression was conducted in HEK293T cells as described [54].
Quantitative PCR and Cytokine array
HCA-7 cells with and without p120 were plated on transwell
filters (pore size 0.3 microns) and cultured for 10 days as described
previously [3]. RNAs were then isolated and quantitated by Real
Time rtPCR [4] and repeated three times.
For cytokine arrays, HCA-7 cells were cultured as above.
Regular media was replaced with serum free media and incubated
for 24 hrs. Conditioned media from top and bottom chambers
were mixed and applied to Human Cytokine Array 5 (RayBio) and
results measured. The positive control value was used to normalize
results from three different experiments. For each cytokine, the
signal from control serum free media was subtracted from WT and
p120KD conditioned media signals. Fold difference was calculated
for each pair of WT/p120KD conditioned media signals and the
average and standard deviation were calculated.
Statistics
To determine statistical significance, the Student’s t-test and
ANOVA were used. A p-value of ,0.05 was considered
statistically significant.
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